Balanced news tone
News Sentiment
FENC sentiment intelligence
Fennec Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
48 relevant articles
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
+0.1% over one week, +15.9% over four weeks, trend active, and materially above fair value.
Understanding the Setup: (FENC) and Scalable Risk
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
76/100 classification
One-week reaction
0.1%
Price digesting
Trend fit
Trend active
15.9% over four weeks
Fair value
37.0%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
8
Neutral
35
Negative
5
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Stock Titan
Direct company coverage
New Fennec hire gets 10,000 stock options at $9, 10-year term
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
GlobeNewswire
Direct company coverage
Fennec Announces Results of Annual Meeting
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Jun 2026 20:30
- Source
- GlobeNewswire
MT Newswires
Direct company coverage
Fennec Announces New Research Supporting Pedmark's Use at ASCO Annual Meeting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 11:21
- Source
- MT Newswires
GlobeNewswire
Direct company coverage
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 22:01
- Source
- GlobeNewswire
Stock Titan
Direct company coverage
Three new Fennec hires get options on 50,000 shares at $9.75
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- Stock Titan
simplywall.st
Direct company coverage
We're Not Worried About Fennec Pharmaceuticals' (NASDAQ:FENC) Cash Burn
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 17 May 2026 07:00
- Source
- simplywall.st
simplywall.st
Industry context
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
GuruFocus.com
Direct company coverage
Fennec Pharmaceuticals Inc (FENC) Q1 2026 Earnings Call Highlights: Record Sales Surge and ...
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 14 May 2026 23:03
- Source
- GuruFocus.com
Moby
Direct company coverage
Fennec Pharmaceuticals Inc. Q1 2026 Earnings Call Summary
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 21:11
- Source
- Moby
Quiver Quantitative
Direct company coverage
FENNEC PHARMACEUTICALS ($FENC) Releases Q1 2026 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Quiver Quantitative
Market source
Industry context
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
simplywall.st
Industry context
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
TradingView
Industry context
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
simplywall.st
Direct company coverage
Fennec Pharmaceuticals (FENC) Quarterly Loss Near Breakeven Challenges Bearish Profitability Narratives
- Tone
- Negative 18/100
- Event
- Market update
- Published
- 25 Mar 2026 07:00
- Source
- simplywall.st
Stock Titan
Direct company coverage
Fennec Pharmaceuticals (FENC) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2025 00:23
- Source
- Stock Titan